Adynxx doses first patient in investigational AYX1 Phase 2 study
The study, which will enroll 90 patients, is designed to demonstrate the safety and efficacy of a single administration of AYX1 given prior to unilateral total knee arthroplasty
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.
Currently, this work is focused on developing and validating new ways for quick forensic screening and analysis based on advanced chromatography and mass-spectrometry systems such as LC-QQQ-MS/MS, LC-QTOF-MS,
Ignyta chairman, CEO, co-founder and MD Jonathan Lim said the collaboration with LUMC will enable Ignyta to study patients with undifferentiated arthritis and rheumatoid arthritis, taking the company
Under the agreement, Viropro will manufacture six monoclonal antibody products, being developed by Oncobiologics, including generic versions of Humira, Rituxan, Avastin, Herceptin, Erbitux and a non-disclosed biotherapeutic used